TABLE 2.

Primary Outcome Analysis for DVT^a

	Early Controlled Motion		Immobilization
	n/N	% (range)	n/N	% (range)	P Value
Intention-to-treat analysis
DVT at any time	33/68	48.5 (36.7-60.4)	28/61	46.8 (35.7-58.4)	.84
DVT at 2 wk	23/68	33.8 (22.6-45.1)	23/62	37.1 (25.6-48.6)	.7
DVT at 8 wk	22/58	37.9 (26.4-49.5)	22/61	36.1 (24.7-47.5)	.83
Developed DVT from 2 to 8 wk	10/58	17.2 (8.3-26.2)	7/61	11.5 (3.9-19.1)	.37
Above-knee DVT at any time	1/68	1.5 (0-4.3)	2/62	3.2 (0-7.4)	≥.999
Per-protocol analysis
DVT at any time	33/67	49.3 (37.4-61.1)	26/56	46.4 (34.6-58.3)	.76
DVT at 2 wk	23/67	34.3 (23.0-45.6)	21/56	37.5 (26.0-49.0)	.72
DVT at 8 wk	22/58	37.9 (26.4-49.5)	20/56	35.7 (24.3-47.1)	.81
Developed DVT from 2 to 8 wk	10/58	17.2 (8.3-26.2)	6/56	10.7 (3.4-18.1)	.32
Above-knee DVT at any time	1/67	1.5 (0-4.4)	2/56	6.6 (0-8.0)	≥.999

^aDVT, deep vein thrombosis. Difference of means was tested using the chi-square or Fisher exact test for dichotomous data.